RecruitingPhase 3NCT07028853This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.Sponsor: PfizerBala-Cynwyd, PA · Lancaster, PA · +125 more sites
RecruitingNot applicableNCT06511141Sacral Neuromodulation for Male Overactive Bladder (MOAB)Sponsor: Axonics, Inc.Bala-Cynwyd, PA · +22 more sites
RecruitingPhase 3NCT07225946A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate CancerSponsor: Janssen Research & Development, LLCAllentown, PA · Bala-Cynwyd, PA · Hershey, PA · +56 more sites
RecruitingPhase 1NCT05413421Study of ORIC-944 in Patients With Metastatic Prostate CancerSponsor: ORIC PharmaceuticalsBala-Cynwyd, PA · Lancaster, PA · +18 more sites
RecruitingPhase 2NCT06134232Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-TSponsor: DendreonBala-Cynwyd, PA · Lancaster, PA · +29 more sites